Blue light devices are available as possible treatment options for psoriasis.
Philips Blue Control is a wearable blue light device for the
treatment of mild psoriasis. On World Psoriasis Day 2017, Philips launched a
new version of the Blue Control – the BlueControl Advance – which reduces the
treatment time from 30 minutes to 15 minutes per plaque.
The BlueControl devices contain light-emitting diodes (LEDs)
that emit blue light. This type of blue light is thought to help regulate the
production of certain skin cells and help to control inflammation, meaning that
it may lead to an improvement in symptoms for some people with psoriasis.
As the popularity of the Philips BlueControl increases, the
Psoriasis Association is asked about the technology by members and followers
more and more often. The clinical data looks promising, and it’s great to see a
treatment option for mild psoriasis that is convenient and mess-free. However,
it is important to remember that, as with all treatment options for psoriasis,
what works for one person will not necessarily work for another. We’re also
naturally fairly cautious about treatments or products that claim not to have
side effects. Whilst it’s true that blue light does not work in the same way as
established UV therapy treatments and therefore is unlikely to have the same side effects, to our
knowledge the long term (ie. over a number of years) effects of blue light
treatment are not yet known.
Because every person with psoriasis is different, it is
important to have as wide a range of treatment options available as possible.
We would always recommend maintaining regular contact with your GP or
Dermatologist, but if you’re looking for an option to help you manage mild
psoriasis at home, then these devices may appeal to you.
The Philips BlueControl and BlueControl Advance devices are not
currently available on the NHS, but can be purchased online through the